Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease. Tang M, Morieri ML, Kalim S, Doria A, et al. J Am Soc Nephrol 2025 Jan 7. doi: 10.1681/ASN.0000000620.

Read + Share

Amedeo Smart

Independent Medical Education

Tang M, Morieri ML, Kalim S, Doria A, et al. Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease. J Am Soc Nephrol 2025 Jan 7. doi: 10.1681/ASN.0000000620.
PMID: 39774583